M&A

Gilead Sciences Buying Achillion Was Twitter Speculation at Its Finest
TheStreet.com
Tue, 05/19/15 - 09:50 am
M&A
social media
twitter
Gilead Sciences
hepatitis C
Achillion
Endo Vaults Into Top 5 Among Generic-Drug Firms
Yahoo/Investors.com
Mon, 05/18/15 - 10:00 pm
generics
Endo International
Par Pharmaceutical
M&A
Perrigo CEO Is Ready to Talk Deal With Mylan at Right Price
Bloomberg
Mon, 05/18/15 - 09:45 pm
Perrigo
Mylan
M&A
Joseph Papa
Hospira approval puts Pfizer on track to close $17bn deal by year's end
In-Pharma Technologist
Mon, 05/18/15 - 11:54 am
Hospira
Pfizer
M&A
Endo to buy Par Pharma for about $8 billion
Marketwatch
Mon, 05/18/15 - 09:00 am
Endo International
Par Pharmaceutical
M&A
AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc.
Yahoo
Sat, 05/16/15 - 02:10 pm
AbbVie
Pharmacyclics
M&A
One more potential Teva-related challenge for Mylan's shareholders: A huge tax bill
BioPharma Dive
Fri, 05/15/15 - 09:52 am
Teva Pharmaceutical
Mylan
M&A
shareholders
taxes
An Attractive M&A Play In The Busy Biotech Space
Forbes
Thu, 05/14/15 - 09:55 am
M&A
biotech
OPKO Health
EirGen Phama
Pharmacyclics-AbbVie Merger Has Many Moving Parts
Seeking Alpha
Wed, 05/13/15 - 11:21 am
AbbVie
Pharmacyclics
M&A
Pfizer continues its deal spree with a $600M option pact to buy AM-Pharma
Fierce Biotech
Tue, 05/12/15 - 11:54 am
Pfizer
M&A
AM-Pharma
Mylan Chairman Considers Perrigo Sweeteners to Make Deal
Yahoo/Bloomberg
Tue, 05/12/15 - 08:14 am
Mylan
M&A
Perrigo
Mylan’s Pursuit of Perrigo Could Yield Massive Synergies
Yahoo/Market Realist
Tue, 05/12/15 - 08:10 am
Mylan
M&A
Perrigo
A Stichting and What It Can Do for Mylan
WSJ Online
Mon, 05/11/15 - 09:28 am
Mylan Labs
M&A
Teva Pharmaceutical
'No path forward' with Teva, Mylan pledges amid warring roadshows
Fierce Pharma
Fri, 05/8/15 - 04:39 pm
Teva Pharmaceutical
Mylan
M&A
Mylan chairman tells investors he would consider buying Teva
Yahoo/Reuters
Fri, 05/8/15 - 04:28 pm
Mylan Labs
Teva Pharmaceutical
M&A
M&A mayhem: Q1 biopharma deal values surpass 2014's grand total
BioPharma Dive
Fri, 05/8/15 - 10:33 am
M&A
Why These 4 Biotech Stocks Could Be the Next Buyout Targets
24/7 Wall St
Thu, 05/7/15 - 09:23 am
biotech
M&A
Biomarin
Bluebird Bio
Incyte
Vertex Pharmaceuticals
Gilead Sciences Acquires EpiTherapeutics
Marketwatch
Wed, 05/6/15 - 11:42 am
M&A
Gilead Sciences
EpiTherapeutics
Alexion Pharma to pay $8.4 billion for rare disease treatment developer Synageva BioPharma
Yahoo/AP
Wed, 05/6/15 - 09:00 am
Alexion
M&A
SynaGeva BioPharma
Teva Completes Acquisition of Auspex Pharmaceuticals
Yahoo
Tue, 05/5/15 - 09:38 am
Teva Pharmaceutical
Auspex Pharmaceuticals
M&A

Pages